Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials · 2000
[Effect of Cordyceps sinensis on the Th1/Th2 cytokines in patients with Condyloma Acuminatum].
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gao Q, Wu G, He D
Аннотация
OBJECTIVE: To investigate the effect of cordyceps sinensis (CS) on the Th1/Th 2 cytokines and recurrence in patients with Condyloma Acuminatum (CA).
METHOD: Double-antibody sandwich ELISA was used to study the serum level of IL-2 and IL-10 in 34 patients treated with CS(CS group) and 29 patients in control group. The recurrence rate of CA was observed.
RESULT: After treated with CS, the serum levels of IL-2 and IL-10 significantly increased and decreased respectively (P < 0.05 or 0.01). No significant change occurred in control group. The recurrence times of CA in patients of CS group after electrocauterization were significantly lower than control group (P < 0.05).
CONCLUSION: CS might recover the balance of Th1/Th2 cytokines and enhance Th 1 immune response in patients with CA, and reduced the recurrence of CA.
METHOD: Double-antibody sandwich ELISA was used to study the serum level of IL-2 and IL-10 in 34 patients treated with CS(CS group) and 29 patients in control group. The recurrence rate of CA was observed.
RESULT: After treated with CS, the serum levels of IL-2 and IL-10 significantly increased and decreased respectively (P < 0.05 or 0.01). No significant change occurred in control group. The recurrence times of CA in patients of CS group after electrocauterization were significantly lower than control group (P < 0.05).
CONCLUSION: CS might recover the balance of Th1/Th2 cytokines and enhance Th 1 immune response in patients with CA, and reduced the recurrence of CA.